Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation

Pancreatic cancer is projected to become the second leading cause of cancer death in the United States by 2030. Deleterious germline mutations can contribute to pancreatic cancer susceptibility. Herein we report a case of a patient with metastatic pancreatic adenocarcinoma to the lung and liver who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Oncol
Main Authors: Palacio, Sofia, Pollack, Terri, Silva-Smith, Rachel, Sussman, Daniel A., Hosein, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6087861/
https://ncbi.nlm.nih.gov/pubmed/30151275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.03.11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados